# Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation

> **NCT03642509** · NA · RECRUITING · sponsor: **University of Aarhus** · enrollment: 750 (estimated)

## Conditions studied

- Atrial Fibrillation
- Stroke

## Interventions

- **DEVICE:** Left atrial appendage occlusion
- **DRUG:** NOAC

## Key facts

- **NCT ID:** NCT03642509
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2030-10-01
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2023-12-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03642509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03642509, "Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03642509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*